Prognostic Values of Baseline ¹⁸F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma

Table 1

Characteristics of patients.

Characteristic	No. of patients ()
Sex (male)	35 (68.63%)
Age median (range)	56 (15-88)
B symptoms (yes)	28 (54.90%)
Ann Arbor stage (III/IV)	41 (80.39%)
	7 (13.73%)
BM (+)	7 (13.73%)
LDH (increased)	24 (47.06%)
IPI
0-1	18 (35.29%)
2	11 (21.57%)
3	14 (27.45%)
4-5	8 (15.69%)
NCCN-IPI
0-3	36 (70.59%)
4-8	15 (29.41%)
No. of extranodal	22 (43.14%)
PIT
0	16 (31.37%)
1	21 (41.18%)
2	10 (19.61%)
3-4	4 (7.84%)
TMTV mean (range)	62.880 (3.81-1485.38)
TLG mean (range)	296.464 (4.8-6497.28)
SUVmax mean (range)	8.48 (1.27-32.65)
Subtype
PTCL-NOS	38 (74.51%)
AITL	8 (15.69%)
ALK-ALCL	5 (9.80%)

Abbreviations: ECOG: Eastern Cooperative Oncology Group; BM: bone marrow; IPI: International Prognostic Index; NCCN-IPI: National Comprehensive Cancer Network International Prognostic Index; PIT: prognostic index for T-cell lymphoma.